Silk Road Medical to Report Third Quarter 2021 Financial Results on November 9, 2021

Rhea-AI Summary

Silk Road Medical, Inc. (NASDAQ: SILK), focused on reducing stroke risk, will report its third quarter 2021 financial results on November 9, 2021, after market close. A conference call for investors will follow at 1:30 p.m. PT (4:30 p.m. ET). Interested listeners can join by dialing (844) 883-3861 domestically or (574) 990-9820 internationally, using conference ID: 3998078. Silk Road Medical is pioneering TransCarotid Artery Revascularization (TCAR) for carotid artery disease treatment, combining surgical neuroprotection with minimally invasive techniques.

Positive

• Upcoming earnings report for Q3 2021 may provide insights into financial health.
• Innovative approach with TCAR positions the company effectively in the stroke prevention market.

Negative

• None.

SUNNYVALE, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the third quarter 2021 after market close on Tuesday, November 9, 2021. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by dialing (844) 883-3861 for domestic callers or (574) 990-9820 for international callers, using conference ID: 3998078. A live and archived webcast of the event will be available at https://investors.silkroadmed.com/.

About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.

Investor Contact
Lynn Lewis or Marissa Bych
Gilmartin Group
investors@silkroadmed.com

FAQ

When will Silk Road Medical report its Q3 2021 financial results?

Silk Road Medical will report its Q3 2021 financial results on November 9, 2021, after market close.

What is the conference call schedule for Silk Road Medical's earnings report?

The conference call will take place on November 9, 2021, at 1:30 p.m. PT (4:30 p.m. ET).

How can I listen to the Silk Road Medical conference call?

Investors can listen to the conference call by calling (844) 883-3861 for domestic or (574) 990-9820 for international access, using conference ID: 3998078.